Búsqueda | Portal de Búsqueda de la BVS Colombia

1.

Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.

MacGlashan, Donald; Saini, Sarbjit; Schroeder, John T.

J Allergy Clin Immunol ; 147(6): 2295-2304.e12, 2021 06.

Artículo en Inglés | MEDLINE | ID: mdl-33716077

2.

The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.

Johal, Kirti J; Chichester, Kristin L; Oliver, Eric T; Devine, Kelly C; Bieneman, Anja P; Schroeder, John T; MacGlashan, Donald W; Saini, Sarbjit S.

J Allergy Clin Immunol ; 147(6): 2271-2280.e8, 2021 06.

Artículo en Inglés | MEDLINE | ID: mdl-33713769

3.

Identifying regulatory pathways of spleen tyrosine kinase expression in human basophils.

Peng, Xia; Zhao, Mingming; Gao, Li; Sen, Ranjan; MacGlashan, Donald.

J Allergy Clin Immunol ; 145(3): 947-957, 2020 03.

Artículo en Inglés | MEDLINE | ID: mdl-31629804

4.

Autoantibodies to IgE and FcÎµRI and the natural variability of spleen tyrosine kinase expression in basophils.

MacGlashan, Donald.

J Allergy Clin Immunol ; 143(3): 1100-1107.e11, 2019 03.

Artículo en Inglés | MEDLINE | ID: mdl-29859965

5.

Association of a SYK promoter polymorphism with SYK expression and IgE-mediated histamine release.

MacGlashan, Donald; Gao, Li.

Clin Exp Allergy ; 53(5): 573-576, 2023 05.

Artículo en Inglés | MEDLINE | ID: mdl-36722389

6.

Dependence of Optimal Histamine Release on Cell Surface IgE Density on Human Basophils: Nature of the Stimulus.

Nejad, Alireza S; MacGlashan, Donald W.

Int Arch Allergy Immunol ; 177(3): 181-191, 2018.

Artículo en Inglés | MEDLINE | ID: mdl-30149387

7.

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels.

MacGlashan, Donald; Alvarez-Arango, Santiago; Tversky, Jody.

Clin Exp Allergy ; 51(8): 1093-1095, 2021 08.

Artículo en Inglés | MEDLINE | ID: mdl-34192382

8.

Vancomycin immediate skin responses in vancomycin-naïve subjects.

Alvarez-Arango, Santiago; Oliver, Eric; Tang, Olive; Saha, Trisha; Keet, Corinne A; Adkinson, N Franklin; MacGlashan, Donald W.

Clin Exp Allergy ; 51(7): 932-935, 2021 07.

Artículo en Inglés | MEDLINE | ID: mdl-33576098

9.

Pros and Cons of Clinical Basophil Testing (BAT).

Hoffmann, Hans Jürgen; Knol, Edward F; Ferrer, Martha; Mayorga, Lina; Sabato, Vito; Santos, Alexandra F; Eberlein, Bernadette; Nopp, Anna; MacGlashan, Donald.

Curr Allergy Asthma Rep ; 16(8): 56, 2016 07.

Artículo en Inglés | MEDLINE | ID: mdl-27411319

10.

Short-wave infrared camera as a novel solution to allergy skin testing.

Tversky, Jody; MacGlashan, Donald.

Allergy ; 75(4): 965-968, 2020 04.

Artículo en Inglés | MEDLINE | ID: mdl-31618452

11.

Blocking antibodies in immunotherapy: Quality versus quantity.

MacGlashan, Donald.

J Allergy Clin Immunol ; 144(5): 1177-1179, 2019 11.

Artículo en Inglés | MEDLINE | ID: mdl-31589878

12.

Reply.

MacGlashan, Donald.

J Allergy Clin Immunol ; 144(2): 623-624, 2019 08.

Artículo en Inglés | MEDLINE | ID: mdl-31202668

13.

Basophil activation testing.

MacGlashan, Donald W.

J Allergy Clin Immunol ; 132(4): 777-87, 2013 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-23958648

14.

Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation.

Macglashan, Donald W; Saini, Sarbjit S.

J Allergy Clin Immunol ; 132(4): 906-11.e1-4, 2013 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-23791510

15.

Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab.

MacGlashan, Donald W; Saini, Sarbjit S.

J Allergy Clin Immunol ; 139(5): 1680-1682.e10, 2017 05.

Artículo en Inglés | MEDLINE | ID: mdl-28259446

16.

Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors.

MacGlashan, Donald W; Savage, Jessica H; Wood, Robert A; Saini, Sarbjit S.

J Allergy Clin Immunol ; 130(5): 1130-1135.e5, 2012 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-22800400

17.

Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy.

Savage, Jessica H; Courneya, Jean-Paul; Sterba, Patricia M; Macglashan, Donald W; Saini, Sarbjit S; Wood, Robert A.

J Allergy Clin Immunol ; 130(5): 1123-1129.e2, 2012 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-22800401

18.

A phase II study of Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis.

Suresh, Ragha V; Dunnam, Collin; Vaidya, Dhananjay; Wood, Robert A; Bochner, Bruce S; MacGlashan, Donald W; Dispenza, Melanie C.

J Clin Invest ; 133(16)2023 08 15.

Artículo en Inglés | MEDLINE | ID: mdl-37384412

19.

Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis: an open-label, phase 2 trial.

Suresh, Ragha V; Dunnam, Collin; Vaidya, Dhananjay; Wood, Robert A; Bochner, Bruce S; MacGlashan, Donald W; Dispenza, Melanie C.

Res Sq ; 2023 Apr 05.

Artículo en Inglés | MEDLINE | ID: mdl-37066249

20.

Glycomic analysis of human mast cells, eosinophils and basophils.

North, Simon J; von Gunten, Stephan; Antonopoulos, Aristotelis; Trollope, Alana; MacGlashan, Donald W; Jang-Lee, Jihye; Dell, Anne; Metcalfe, Dean D; Kirshenbaum, Arnold S; Bochner, Bruce S; Haslam, Stuart M.

Glycobiology ; 22(1): 12-22, 2012 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-21725073

Portal de Búsqueda de la BVS Colombia

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.

The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.

Identifying regulatory pathways of spleen tyrosine kinase expression in human basophils.

Autoantibodies to IgE and FcÎµRI and the natural variability of spleen tyrosine kinase expression in basophils.

Association of a SYK promoter polymorphism with SYK expression and IgE-mediated histamine release.

Dependence of Optimal Histamine Release on Cell Surface IgE Density on Human Basophils: Nature of the Stimulus.

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels.

Vancomycin immediate skin responses in vancomycin-naïve subjects.

Pros and Cons of Clinical Basophil Testing (BAT).

Short-wave infrared camera as a novel solution to allergy skin testing.

Blocking antibodies in immunotherapy: Quality versus quantity.

Reply.

Basophil activation testing.

Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation.

Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab.

Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors.

Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy.

A phase II study of Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis.

Bruton's tyrosine kinase inhibition for the prevention of anaphylaxis: an open-label, phase 2 trial.

Glycomic analysis of human mast cells, eosinophils and basophils.